These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22123347)

  • 1. Implementing a perinatal substance abuse screening tool.
    Wallman CM; Smith PB; Moore K
    Adv Neonatal Care; 2011 Aug; 11(4):255-67. PubMed ID: 22123347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal illicit drug screening practices in mother-newborn dyads at a university hospital serving rural/semi-urban communities: translation of research to quality improvement.
    Oral R; Koc F; Bayman EO; Assad A; Austin A; Strang T; Bayman L
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2441-6. PubMed ID: 22716202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal toxicology screening.
    Hansen RL; Evans AT; Gillogley KM; Hughes CS; Krener PG
    J Perinatol; 1992 Sep; 12(3):220-4. PubMed ID: 1432276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal screening for drugs of abuse: reassessment of current practice in a high-risk area.
    Schulman M; Morel M; Karmen A; Chazotte C
    Am J Perinatol; 1993 Sep; 10(5):374-7. PubMed ID: 8240597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal screening for illicit drugs: policies in hospitals in a large metropolitan area.
    Birchfield M; Scully J; Handler A
    J Perinatol; 1995; 15(3):208-14. PubMed ID: 7666270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary report of knowledge translation: lessons from taking screening and brief intervention techniques from the research setting into regional systems of care.
    Bernstein E; Topp D; Shaw E; Girard C; Pressman K; Woolcock E; Bernstein J
    Acad Emerg Med; 2009 Nov; 16(11):1225-33. PubMed ID: 20053242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for out-of-home custody child care among families with alcohol and substance abuse problems.
    Sarkola T; Kahila H; Gissler M; Halmesmäki E
    Acta Paediatr; 2007 Nov; 96(11):1571-6. PubMed ID: 17850394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R; McCune S; Feibus K
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.
    Ostrea EM; Brady M; Gause S; Raymundo AL; Stevens M
    Pediatrics; 1992 Jan; 89(1):107-13. PubMed ID: 1727992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is meconium screening appropriate for universal use? Science and ethics say no.
    Marcellus L
    Adv Neonatal Care; 2007 Aug; 7(4):207-14. PubMed ID: 17700195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
    Pichini S; Puig C; Zuccaro P; Marchei E; Pellegrini M; Murillo J; Vall O; Pacifici R; García-Algar O
    Forensic Sci Int; 2005 Oct; 153(1):59-65. PubMed ID: 15923097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted perinatal drug screening in a rural population.
    O'Connor TA; Bondurant HH; Siddiqui J
    J Matern Fetal Med; 1997; 6(2):108-10. PubMed ID: 9086427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and fetal effects from substance use.
    Rayburn WF
    Clin Perinatol; 2007 Dec; 34(4):559-71, vi. PubMed ID: 18063105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-of-abuse testing in the neonate.
    Reinarz SE; Ecord JS
    Neonatal Netw; 1999 Dec; 18(8):55-61. PubMed ID: 11885073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
    J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn drug testing practices in Iowa birthing hospitals.
    Wood KE; Smith P; Krasowski MD
    J Neonatal Perinatal Med; 2017; 10(4):445-450. PubMed ID: 29286931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staff training makes a difference: improvements in neonatal illicit drug testing and intervention at a tertiary hospital.
    Oral R; Koc F; Jogerst K; Bayman L; Austin A; Sullivan S; Bayman EO
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1049-54. PubMed ID: 24060204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.